文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

每日在线自适应放疗用于子宫内膜癌和宫颈癌术后并将PTV边界缩小至5 mm:剂量学结果、急性毒性和首次临床经验

Daily Online Adaptive Radiation Therapy of Postoperative Endometrial and Cervical Cancer With PTV Margin Reduction to 5 mm: Dosimetric Outcomes, Acute Toxicity, and First Clinical Experience.
PubMed 文献 · Adv Radiat Oncol · 2024-04-13

这项前瞻性研究纳入17例接受每日iCBCT引导在线自适应放疗的子宫内膜癌和宫颈癌术后患者,PTV均匀边界缩小至5 mm,处方为45或50.4 Gy/1.8 Gy。全部434分次均选择自适应计划,CTV和PTV剂量覆盖改善,阴道PTV覆盖提高近7%(P<.05),膀胱和直肠Dmean显著降低,急性毒性低。

要点

  • 17例术后患者接受每日iCBCT引导在线自适应放疗,PTV边界缩小至5 mm。
  • 全部434分次均选择自适应计划,阴道PTV覆盖提高近7%(P<.05)。
  • 2级急性胃肠道毒性24%,2级泌尿生殖毒性0,1例3级白细胞减少。

核心结论

  • 每日在线自适应放疗与剂量学改善和低急性毒性相关,支持其用于子宫内膜癌和宫颈癌术后治疗的安全性和有效性。
  • 这些结果需要在更大的前瞻性随机对照队列中验证。

研究设计与样本

  • 前瞻性研究,连续纳入17例接受每日iCBCT引导在线自适应放疗的子宫内膜癌和宫颈癌术后患者。
  • PTV采用缩小的均匀三维边界5 mm,计划处方为45或50.4 Gy,每日1.8 Gy分次照射PTV。
  • 治疗前后行超声和iCBCT扫描记录分次内膀胱和直肠体积变化,评估勾画准确性、在线自适应放疗流程时间、剂量学结果和急性毒性。

主要发现

  • 从首次iCBCT采集到治疗完成的平均时间为22分26秒。
  • 在此期间,基于iCBCT勾画的膀胱体积增加44 cm³,直肠体积保持稳定(治疗前62.9 cm³ vs 治疗后61.9 cm³)。
  • 91.6%的危及器官和88.1%的CTV无需或仅需轻微编辑。
  • 全部434分次均选择自适应计划,CTV和PTV剂量覆盖显著改善,阴道PTV覆盖提高近7%(P<.05)。
  • 自适应计划的膀胱Dmean为104.61 cGy、直肠Dmean为123.67 cGy,分别显著低于预定计划的108.24 cGy和128.19 cGy;骨髓和左右股骨头剂量学也随自适应改善。

关键数值与推荐

  • 2级急性胃肠道毒性发生率为24%,2级急性泌尿生殖毒性为0。
  • 1例患者出现3级急性毒性(白细胞计数下降)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 这些结果需要在更大的前瞻性随机对照队列中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study evaluated the first clinical implementation of daily iterative cone beam computed tomography (iCBCT)-guided online adaptive radiation therapy (oART) in the postoperative treatment of endometrial and cervical cancer. METHODS AND MATERIALS: Seventeen consecutive patients treated with daily iCBCT-guided oART were enrolled in this prospective study, with a reduced uniform 3-dimensional PTV margin of 5 mm. Treatment plans were designed to deliver 45 or 50.4 Gy in 1.8 Gy daily fractions to PTV. Pre- and posttreatment ultrasound and iCBCT scans were performed to record intrafractional bladder and rectal volume changes. The accuracy of contouring, oART procedure time, dosimetric outcomes, and acute toxicity were evaluated. RESULTS: The average time from first iCBCT acquisition to completion of treatment was 22 minutes and 26 seconds. During this period, bladder volume increased by 44 cm3 using iCBCT contouring, whereas rectal volume remained stable (62.9 cm3 pretreatment vs 61.9 cm3 posttreatment). A total of 91.6% of influencers and 88.1% of CTVs required no or minor edits. The adapted plan was selected in all (434) fractions and significantly improved the dosimetry coverage for CTV and PTV, especially the vaginal PTV coverage by nearly 7% (P < .05). The adapted bladder Dmean was 104.61 cGy, and the rectum Dmean was 123.67 cGy, significantly lower than the scheduled plan of 108.24 and 128.19 cGy, respectively. The bone marrow and femur head left and right dosimetry were also improved with adaptation. Grade 2 acute gastrointestinal and genitourinary toxicities were 24% and 0, respectively. There was a grade 3 acute toxicity of decreased white blood cell count in 1 patient. CONCLUSIONS: Daily oART was associated with favorable dosimetry improvement and low acute toxicity, supporting its safety and efficacy for postoperative treatment of endometrial and cervical cancer. These results need to be validated in a larger prospective randomized controlled cohort.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Wang G, Wang Z, Zhang Y, et al. Daily Online Adaptive Radiation Therapy of Postoperative Endometrial and Cervical Cancer With PTV Margin Reduction to 5 mm: Dosimetric Outcomes, Acute Toxicity, and First Clinical Experience. Adv Radiat Oncol. 2024. PMID: 38826155. doi:10.1016/j.adro.2024.101510

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。